These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1848069)

  • 21. Infection of the adrenal gland as a route to the central nervous system after viraemia with herpes simplex virus in the mouse.
    Hill TJ; Yirrell DL; Blyth WA
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():309-20. PubMed ID: 3003239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
    Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
    J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site.
    Klein RJ; Friedman-Kien AE; Brady E
    Arch Virol; 1978; 57(2):161-6. PubMed ID: 208489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl- L-lysine on resistance to herpes simplex virus type-1 infection in cyclophosphamide-treated mice.
    Ishihara C; Iida J; Mizukoshi N; Yamamoto N; Yamamoto K; Kato K; Azuma I
    Vaccine; 1989 Aug; 7(4):309-13. PubMed ID: 2554602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus.
    Altmann DM; Blyth WA
    Clin Exp Immunol; 1985 Jan; 59(1):17-22. PubMed ID: 2982525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of purified glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Nishiyama K; Ohtomo N; Mori R
    Arch Virol; 1986; 89(1-4):69-80. PubMed ID: 3013134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity.
    Kapoor AK; Nash AA; Wildy P
    J Gen Virol; 1982 Jul; 61 (Pt l)():127-31. PubMed ID: 6288848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment.
    Kurata T; Kurata K; Aoyama Y
    Jpn J Exp Med; 1978 Oct; 48(5):427-35. PubMed ID: 219274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus.
    Pack CD; Kumaraguru U; Suvas S; Rouse BT
    Vaccine; 2005 May; 23(27):3526-34. PubMed ID: 15855011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppression of mice by cyclophosphamide (CyP) and cyclosporin A (CsA) changes the course of HSV-1 infection and the distribution of viral DNA in target organs.
    Berkowitz-Balshayi C; Rösen-Wolff A; Darai G; Becker Y
    In Vivo; 1995; 9(2):155-62. PubMed ID: 7548792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    Rager-Zisman B; Allison AC
    J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marrow-dependent cells depleted by 89Sr mediate genetic resistance to herpes simplex virus type 1 infection in mice.
    Lopez C; Ryshke R; Bennett M
    Infect Immun; 1980 Jun; 28(3):1028-32. PubMed ID: 6249746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-induced demyelination in herpes simplex virus-infected mice.
    Kristensson K; Svennerholm B; Vahlne A; Nilheden E; Persson L; Lycke E
    J Neurol Sci; 1982 Feb; 53(2):205-16. PubMed ID: 7057211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral activity of interferon in rats and the effect of immune suppression.
    Schellekens H; Smiers-de Vreede E; de Reus A; Dijkema R
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():391-6. PubMed ID: 6198453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system susceptibility to herpes simplex infection.
    Townsend JJ; Baringer JR
    J Neuropathol Exp Neurol; 1978 May; 37(3):255-62. PubMed ID: 207826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis by RNA-PCR of latency and reactivation of herpes simplex virus in multiple neuronal tissues.
    Tanaka S; Minagawa H; Toh Y; Liu Y; Mori R
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2691-8. PubMed ID: 7931155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2.
    Caspary L; Schindling B; Dundarov S; Falke D
    Arch Virol; 1980; 65(3-4):219-27. PubMed ID: 6251783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection.
    Reading PC; Whitney PG; Barr DP; Smyth MJ; Brooks AG
    Eur J Immunol; 2006 Apr; 36(4):897-905. PubMed ID: 16552715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.